AJNA Biosciences Applies to Make Psilocybin and Psilocyn in Colorado
Estimated reading time: 2–3 minutes
What AJNA Wants to Do
AJNA Biosciences wants to make mushrooms that contain Psilocybin and Psilocyn. These are both schedule I controlled substances. The company’s work is for internal research, clinical trials, and analysis. AJNA also wants to sell these substances to its customers who do schedule I clinical research.
Where and When
AJNA Biosciences is located at 8022 Southpark Circle, Suite 500, Littleton, Colorado 80120-5659. The company sent its application on May 7, 2025.
Rules and Details
The DEA says this notice is made under 21 CFR 1301.33(a). Anyone who is a registered bulk manufacturer or an applicant for the same substances can comment or object. They have until August 18, 2025, to do this. They may also ask for a hearing by the same date.
How to Comment
Comments need to be sent electronically through the Federal eRulemaking Portal at https://www.regulations.gov. People can write short comments or attach longer files. After sending a comment, a Comment Tracking Number is given. Comments may not show up right away on the site.
Who Signed the Notice
Matthew Strait, Deputy Assistant Administrator at the DEA, signed the notice.
No activities except for those listed are allowed for this registration.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
